CC

Chetan Channappa Hatarki

Active Director Designated Partner DIN 09335379
DIN 09335379 First appointment Sep 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Chetan Channappa Hatarki

Data last updated:

Chetan Channappa Hatarki is a Designated Partner at Reckonin Pharmaceuticals Llp (since 2021). The company operates in Pharma.

DIN 09335379
Primary Designation Designated Partner
Industry Pharma
First Appointment 27 Sep 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner27 Sep 20212021Active

Board colleagues of Chetan Channappa Hatarki

NameDINCompanyDesignation
Namrata Raghavendra Kulkarni10272164Reckonin Pharmaceuticals LlpDesignated Partner
Prema Hulagappa Kavalli09335380Reckonin Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Reckonin Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Chetan Channappa Hatarki

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chetan Channappa Hatarki

Chetan Channappa Hatarki currently holds 1 directorship: Reckonin Pharmaceuticals Llp (Designated Partner, since 27 Sep 2021).

Chetan Channappa Hatarki was first appointed on 27 Sep 2021 as Designated Partner at Reckonin Pharmaceuticals Llp.

The current boards of Chetan Channappa Hatarki's companies include Namrata Raghavendra Kulkarni (Reckonin Pharmaceuticals Llp), Prema Hulagappa Kavalli (Reckonin Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available